Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Sleep Apnoea Syndrome Correlated with Progression of Normal Tension Glaucoma
Author Affiliations & Notes
  • Ella Claire Berry
    Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia
  • Henry Marshall
    Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia
  • Mark Hassall
    Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia
  • Antonia Kolovos
    Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia
  • Joshua Schmidt
    Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia
  • Sean Mullany
    Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia
  • Stewart Lake
    Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia
  • Anna Galanopoulos
    Discipline of Ophthalmology and Visual Sciences, The University of Adelaide, Adelaide, South Australia, Australia
  • John Landers
    Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia
  • Paul Healey
    Centre for Vision Research, University of Sydney, Sydney, New South Wales, Australia
  • Stuart L Graham
    Faculty of Health and Medical Sciences, Macquarie University, Sydney, New South Wales, Australia
  • Alex W Hewitt
    Department of Ophthalmology, University of Tasmania Menzies Institute for Medical Research, Hobart, Tasmania, Australia
  • Stuart MacGregor
    QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
  • Robert Casson
    Discipline of Ophthalmology and Visual Sciences, The University of Adelaide, Adelaide, South Australia, Australia
  • Owen Siggs
    Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
  • Jamie E Craig
    Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia
  • Footnotes
    Commercial Relationships   Ella Berry None; Henry Marshall None; Mark Hassall Seonix Bio, Code I (Personal Financial Interest); Antonia Kolovos None; Joshua Schmidt None; Sean Mullany None; Stewart Lake None; Anna Galanopoulos None; John Landers None; Paul Healey None; Stuart Graham None; Alex Hewitt None; Stuart MacGregor Seonix Bio, Code I (Personal Financial Interest), Seonix Bio, Code O (Owner), Seonix Bio, Code P (Patent); Robert Casson None; Owen Siggs Seonix Bio, Code I (Personal Financial Interest), Seonix Bio, Code O (Owner), Seonix Bio, Code S (non-remunerative); Jamie Craig Seonix Bio, Code I (Personal Financial Interest), Seonix Bio, Code O (Owner), Seonix Bio, Code P (Patent)
  • Footnotes
    Support  This work was funded by the National Health and Medical Research Council (NHMRC program grant APP1150144, and project grant APP1157571). JEC by a NHMRC Practitioner Fellowship and OMS by a Snow Fellowship.
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 2766. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ella Claire Berry, Henry Marshall, Mark Hassall, Antonia Kolovos, Joshua Schmidt, Sean Mullany, Stewart Lake, Anna Galanopoulos, John Landers, Paul Healey, Stuart L Graham, Alex W Hewitt, Stuart MacGregor, Robert Casson, Owen Siggs, Jamie E Craig; Sleep Apnoea Syndrome Correlated with Progression of Normal Tension Glaucoma. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2766.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the relationship between sleep apnoea status and the longitudinal structural and functional progression in normal tension suspect and early manifest glaucoma patients.

Methods : Three hundred and twenty-five suspect and early manifest glaucoma patients from the Progression Risk of Glaucoma: RElevant SNPs with Significant Association (PROGRESSA) study wore a pulse oximeter for three consecutive nights. Sleep apnoea syndrome was defined by the presence of an oxygen desaturation index (ODI) ≥ 10 on at least two nights of pulse oximetry monitoring. Patients were categorized to normal tension if they had no recorded intraocular pressures >21mmHg. In 173 normal tension participants a multivariate mixed effect regression analysis assessed the correlation between the presence of sleep apnoea syndrome and the retrospective rate of Spectral-Domain Optical Coherence Tomography (SD-OCT) macular ganglion cell-inner plexiform layer (mGCIPL) thinning. Secondary analysis assessed the correlation between the presence of sleep apnoea syndrome and visual field rate of change in mean deviation (MD/year). Age, gender, intraocular pressure and body mass index (BMI) were included as covariates.

Results : For normal tension participants in the PROGRESSA study, a sleep apnoea diagnosis conferred a 0.3 μm/year faster rate of mGCIPL thinning (β: -0.22 μm/year/SD 95% CI [-0.39, -0.06] P=0.009). This association persisted after adjustment for cardiovascular traits (hypertension, diabetes, smoking history) (β: -0.219 μm/year/SD 95% CI [-0.395, -0.042] P=0.017). Furthermore, a greater number of nights with an ODI ≥ 10 was associated with a faster rate of mGCIPL thinning (β: -0.08 μm/year/night 95% CI [-0.02, -0.14] P=0.01). In this normal tension cohort, a secondary analysis of visual field rate of change demonstrated participants with sleep apnoea syndrome exhibited faster rates of visual field deterioration (β: -0.16 dB/year 95% CI [-0.003, -0.31] P=0.045).

Conclusions : Normal tension suspect and early manifest glaucoma participants with sleep apnoea syndrome exhibited faster rates of mGCIPL thinning and faster visual field deterioration. These results implicate sleep apnoea as a relevant covariate of neuroretinal degeneration, which may be clinically relevant in normal tension glaucoma disease progression.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×